Permanent blindness or vision loss after a car accident

• Lifetime Care (icare): Claimants with permanent blindness are often eligible for the Lifetime Care and Support Scheme, which pays for all reasonable and necessary care and rehab.
• Statutory Benefits: Immediate funding for medical treatment and weekly income support through the CTP insurer.
• Common Law Damages: For significant, permanent vision loss, you may be eligible to claim lump sum damages for economic loss and pain and suffering.

Claims for vision loss rely heavily on ophthalmological assessments. This includes measurements of visual acuity, visual fields, and the clinical link between the accident trauma and the resulting impairment.

• Emergency, ophthalmology and imaging records showing the injury mechanism and early visual change
• Specialist reports on prognosis, permanence, and functional vision loss
• Mobility, assistive technology, and care recommendations explaining why supports are needed
• Work, driving, reading and day-to-day function evidence showing practical impact over time

If the insurer disputes treatment, supports, or the severity of impairment, it can help to map the issue against CTP dispute pathways, PIC review options, and the WPI threshold framework.

In practice, contested files are stronger when claimants keep a dated orientation-and-safety log (near misses, route changes, low-light incidents, and assistive-device failures) and cross-reference each event to treating reviews. This helps convert abstract vision complaints into insurer-testable evidence.

Where an insurer relies narrowly on single-point acuity or field data, claimant responses are often more persuasive when they map specialist methodology against the Motor Accident Guidelines and the WPI assessment framework, then show why day-to-day safety and support-need evidence cannot be collapsed into one isolated test result.

For disputed matters, outcomes are usually stronger when evidence is separated into three streams: (1) treatment/support necessity, (2) impairment methodology and WPI framing, and (3) settlement-readiness material (work capacity, transport, care, and assistive-tech costs). Running all three streams in one blended response often weakens each issue.

• Mechanism and timing: insurers often test whether the visual loss arose directly from the crash, later complications, or an unrelated condition. Early trauma, ophthalmology, imaging, and hospital records matter.
• Functional loss versus headline diagnosis: a claimant usually needs more than the label of retinal, optic-nerve, or ocular injury. Good files explain reading limits, mobility risk, driving loss, screen intolerance, falls risk, and changed work capacity.
• Treatment and support necessity: where mobility training, assistive technology, home modifications, transport, or attendant care are disputed, the evidence should explain why the support is reasonable and necessary in practical terms, not just clinically desirable.
• Impairment methodology: if the insurer relies on a narrow view of visual acuity or fields, it helps to compare the specialist methodology against the relevant Motor Accident Guidelines and the broader WPI assessment framework.
• Correct dispute pathway selection: some issues are really about treatment/support approval, others about impairment, and others about settlement readiness. Keeping them separated usually makes internal review and PIC escalation stronger.

Where insurers rely on one accompanied outing, the response is strongest when it separates assisted performance from independent performance. A short table comparing supervision level, route risk, and post-activity recovery can show why the activity was possible on that day but not reliably repeatable without supports in ordinary weekly life.

The safest next step is to identify the decision you are trying to answer before sending more material. A treatment-support request, an internal review, a WPI assessment, a Lifetime Care question and a settlement-preparation issue each need a different evidence bundle. Keeping those streams separate helps the insurer, icare or the Personal Injury Commission (PIC) test the right facts without blurring the issue.

• For immediate treatment or support funding, start with the treatment and rehabilitation support guide and match each requested item to function and safety evidence.
• For an insurer refusal, check whether the next step is an internal review or a PIC dispute, then respond to the exact reasons given.
• For long-term impairment or damages, keep the WPI threshold, work capacity, care schedules and future-treatment material separate from short-term approval disputes.
• For severe permanent support needs, compare the CTP insurer pathway with the Lifetime Care and Support Scheme so requests are directed to the right decision-maker.

This page is general information, not a prediction of entitlement. Vision-loss claims turn on diagnosis, causation, functional impact, statutory wording, medical evidence and the specific decision under review.

• Relying on one short specialist letter without the treating chronology, imaging, rehab, orientation/mobility, or function evidence behind it.
• Assuming Lifetime Care, statutory benefits, WPI, and damages issues are all the same dispute when each may need different evidence and timing.
• Ignoring insurer IME reasoning until late instead of responding point by point while the review window is open.
• Undervaluing employment, screen-use, licence, education, and independence consequences when building the claim narrative.
• Moving toward settlement before prognosis, supports, future treatment, and impairment consequences are properly documented.

Another common mistake is accepting support reductions based on one “good day” before testing repeatability. If support hours are being cut, ask for a time-limited trial with clear safety triggers, incident logging, and a review date so the insurer decision is grounded in real reliability data rather than optimism.